Stocks Eli Lilly and Co

More

  • picks_pans_badge.jpg

    There's nearly $3.5 trillion dollars waiting to be invested in the markets, according to Frederic Dickson, chief market strategist  of D.A. Davidson.  So what's keeping it out?  And what should investors do in the meantime?

  • Eli Lilly's drug Zyprexa.

    U.S. regulators have rejected a long-acting injectable form of Eli Lilly and Co's blockbuster schizophrenia drug Zyprexa, the company said Thursday, sending its shares down almost 2 percent.

  • When Schering-Plough Chairman and CEO Fred Hassan recently decided to buy another $2 million worth of SGP shares in the wake of the Vytorin study takedown, the company put out a press release.

  • Healthcare spending is expected to nearly double to $4.3 trillion by 2017. Who’s most likely to benefit and can you trade it?

  • hillary_pfizer.jpg

    According to The Center for Responsive Politics' web site Pfizer Chairman and CEO Jeff Kindler has opened his wallet again for Sen. Hillary Clinton. You can see his latest "give" here. Twice now within the past year Kindler has given the maximum amount ($2,300) an individual can contribute to a candidate.

  • graphic_fast_money.jpg

    A top industry insider gives us the dish on a story of the week. Get the details now!

  • Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • 0800213 Pfizer.jpg

    With a 5.6% dividend yield, Pfizer is currently the highest yielding stock in the Dow Jones Industrial Average and ranks 20th in yield on the S&P 500.  As a point of comparison, 30 Yr treasuries and the Lehman Aggregate Bond Index are yielding about 4.5%.  The Lehman Corporate Bond Index is yielding 5.55%. So is it the time to buy PFE?

  • graphic_word_ofthe_street.jpg

    Stocks lost ground Monday, coming off their best week in nearly five years. What's the word on the Street?

  • graphic_word_ofthe_street.jpg

    The Dow gives up a 200-point gain as traders second guess the Fed decision. Fast Money offers some clarity on the future - as well as a ton of after-hours action - in the Word on the Street.

  • Eli Lilly's drug Zyprexa.

    abstract goes here

  • Eli Lilly posted a higher fourth-quarter profit Tuesday. The pharmaceutical firm cited lower taxes and better-than-expected drug sales -- especially sales of its newer formulations for diabetes and cancer. John Lechleiter, president and chief operating officer -- and Lilly's CEO as of April 1 -- gave CNBC his strong earnings outlook.

  • Byetta Needle

    Direct-to-consumer pharmaceutical advertising is everywhere in American media because it works. Generally speaking, it drives patients to ask/tell their doctors to prescribe a particular medication.

  • Eli Lilly Tuesday said fourth-quarter profit rose on lower taxes and better-than-expected sales of its medicines, including its newer treatments for depression, diabetes and cancer.

  • Despite recent market upheavals, Sidney Taurel, CEO of Eli Lilly, says he is not convinced the pharmaceuticals sector will be negatively impacted. “The pharmaceutical industry is not that affected by business cycles, and so I believe this financial and possible economic crisis isn’t going to affect significantly our company or the industry.”

  • The show was over, but Cramer kept going. Don't miss his in-depth answers to audience questions about Merck, Target and more.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Eli Lilly

    For the second time this week, big pharma is taking a beating from critical reports about medications. This time, it's antidepressants. But one analyst thinks the drag on shares is overdone -- and names "exciting" pharma stocks.